Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy

Gene Therapy

Volumn 7, Issue 15, 2000, Pages 1317-1325

  Putzer, B M ^a   Stiewe, T ^a   Crespo, F ^a   Esche, H ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Adenovirus; Apoptosis; Cancer; E2F1; ER fusion protein; Gene therapy

Indexed keywords

ESTROGEN RECEPTOR; HYBRID PROTEIN; LIGAND; TAMOXIFEN; TRANSCRIPTION FACTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENETICS; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; TRANSGENE; TUMOR CELL;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 0033869428     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301235     Document Type: Article

References (35)

1. Self-contained teracycline-regulated retroviral vector system for gene delivery to mammalian cells
2. Ecdysone-inducible gene expression in mammalian cells and transgenic mice
3. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
4. Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts
5. Deregulated c-myc expression in quiescent CHO cells induces target gene transcription and subsequent apoptotic phenotype
6. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase
7. Endocrine pharmacology of antiestrogens as antitumor agents
8. Human adenovirus vectors for gene transfer into mammalian cells
9. Adenovirus-mediated overexpression of the transcription factor E2F1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53
10. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo
11. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines
12. Gene therapy for gliomas: P53 and E2F-1 proteins and the target of apoptosis
13. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer
14. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: Efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models
15. Comparison of the human versus murine cytomegalovirus immediate-early gene promoters for transgene expression by adenoviral vectors
16. Interleukin-12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
17. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
18. Construction and propagation of human adenovirus vectors
19. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization
20. Modulation of c-Myc activity and apoptosis in vivo
21. Adenovirus-mediated regulable target gene expression in vivo
22. A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax
23. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
24. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis
25. Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis
26. A rapid alkaline extraction procedure for screening recombinant plasmid DNA
27. Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry
28. Manipulation of adenovirus vectors
29. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression
30. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction
31. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
32. Electroporation intracellular buffer increases cell survival
33. E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products